Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of
surviving extremely preterm infants and is associated with significant health care utilization …

Bronchopulmonary Dysplasia (BPD) is a multifactorial disease affecting over 35% of
extremely preterm infants born each year. Despite the advances made in understanding the …

Bronchopulmonary dysplasia (BPD) is the most prevalent long-term morbidity in surviving
extremely preterm infants and is linked to increased risk of reactive airways disease …

Bronchopulmonary dysplasia (BPD) is a major complication of preterm birth and has serious
adverse long‐term health consequences. The etiology of BPD is complex, multifactorial, and …

Bronchopulmonary dysplasia (BPD) is a disease of complex and multifactorial etiology and
a major cause of morbidity in premature infants. Contributing factors include infection …

Pathogenesis and treatment of bronchopulmonary dysplasia : Current Opinion in Pediatrics
Pathogenesis and treatment of bronchopulmonary dysplasia : Current Opinion in Pediatrics …

Bronchopulmonary dysplasia (BPD) is a chronic lung disease most commonly seen in
premature infants who required mechanical ventilation and oxygen therapy for acute …

Bronchopulmonary dysplasia (BPD), also known as chronic lung disease (CLD), is one of
the most challenging complications in premature infants. The incidence of BPD has been …

Introduction: As more infants are surviving at younger gestational ages, bronchopulmonary
dysplasia (BPD) remains as a frequent neonatal complication occurring after preterm birth …

Bronchopulmonary dysplasia (BPD) remains an important sequelae of neonatal intensive
care. Substantial advances in current understanding of the pathogenesis and …